Australian MPs visit Southport GP to learn about low carb diet for type 2 diabetes

Source: BMJ News - Category: General Medicine Source Type: research

Related Links:

TYPE 2 diabetes can be controlled by eating the right kind of diet, but this can be difficult when balancing a busy schedule and eating on the go. There is one simple and tasty lunch which can fill you up and stop you from snacking on unhealthy foods while preventing blood sugar spikes.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Conclusion: Invasive fungal infections may also be a causative pathogen in deep tissue infections. Therefore, fungal pathogens should be considered in patients unresponsive to long-term antibiotic therapy. Early detection of fungal infections in high-risk individuals is critical for the prevention of severe consequences such as foot amputation. PMID: 30761877 [PubMed - in process]
Source: Turkish Journal of Medical Sciences - Category: General Medicine Tags: Turk J Med Sci Source Type: research
Conclusion: Understanding the normal β-cell function and identifying the defects in β-cell function that lead to the development of diabetes will generate new therapeutic targets PMID: 30761839 [PubMed - in process]
Source: Turkish Journal of Medical Sciences - Category: General Medicine Tags: Turk J Med Sci Source Type: research
Authors: Wu HX, Tang J, Li L, Liu SP, Zhou ZG, Yang JX, Yan DW, Zhou HD Abstract Type 2 diabetic patients are becoming younger and having a tendency to family aggregation, they are easily suspected as maturity-onset diabetes of young (MODY) in the outpatient clinic and send to genetic testing. 9 diabetic families were compared in our outpatient clinic who met the primary diagnosis criteria of MODY. Detailed clinical features and laboratory data including gene sequence were collected and analyzed. The patients met the primary clinical diagnostic criteria of MODY for genetic testing at the first look. However, member...
Source: Endocrine Journal - Category: Endocrinology Tags: Endocr J Source Type: research
CONCLUSIONS: Ertugliflozin was well tolerated and provided clinically meaningful glycemic control and durable reductions in body weight and SBP over 104 weeks. identifier NCT01999218. PMID: 30760125 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
ConclusionSynchronous VHR and BS in a bariatric unit is feasible with low recurrence rate. Laparoscopic VHR has lower complication rates than open, apart from seroma formation. Patients with diabetes have higher risk of infection.
Source: Surgical Endoscopy - Category: Surgery Source Type: research
Publication date: Available online 14 February 2019Source: Clinica Chimica ActaAuthor(s): Neetu Mishra, Gauri Damle, Yogita Dhas, Joyita BanerjeeAbstractBackgroundVitamin D deficiency contributes to the pathophysiology of insulin resistance (IR) and type 2 diabetes mellitus (T2DM). We investigated the association of 25-hydroxyvitamin D [25(OH)D] with IR and β-cell function in middle-aged participants.MethodsWe enrolled 90 controls and 90 T2DM patients of both genders aged 30–50 y. Serum 25(OH)D, fasting plasma insulin (FPI), fasting plasma glucose (FPG), HbA1c, and lipid profile were measured by standard methods...
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
Authors: Pouwels S, Topal B, Knook MT, Celik A, Sundbom M, Ribeiro R, Parmar C, Ugale S Abstract INTRODUCTION: Obesity, defined as a Body Mass Index (BMI) of ≥30 kg/m2, is the most common chronic metabolic disease worldwide and its prevalence has been strongly increasing. Obesity is associated with various diseases such as cardiovascular disease, type 2 diabetes and hypertension. Regarding heart rhythm disorders, obesity is associated with an increase in atrial fibrillation (AF), the most common arrhythmia in clinical practice. AF is associated with an increased cardiovascular morbidity and mortality. Obesity, a...
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research
Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Gemigliptin 50mg;   Drug: Gemigliptin Placebo Sponsor:   LG Chem Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Condition:   Type 2 Diabetes Mellitus Intervention:   Other: Personalized Risk Communication for People with Type 2 Diabetes Sponsors:   University of Oxford;   NIHR Collaboration for Leadership in Applied Health Research and Care (Oxford) Completed
Source: - Category: Research Source Type: clinical trials
More News: Australia Health | Diabetes | Diabetes Type 2 | Diets | Endocrinology | General Medicine | Learning | Nutrition | Universities & Medical Training